1. Home
  2. NEUP vs SISI Comparison

NEUP vs SISI Comparison

Compare NEUP & SISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEUP
  • SISI
  • Stock Information
  • Founded
  • NEUP 1996
  • SISI 1997
  • Country
  • NEUP United States
  • SISI China
  • Employees
  • NEUP N/A
  • SISI N/A
  • Industry
  • NEUP
  • SISI Medicinal Chemicals and Botanical Products
  • Sector
  • NEUP
  • SISI Health Care
  • Exchange
  • NEUP Nasdaq
  • SISI Nasdaq
  • Market Cap
  • NEUP 12.7M
  • SISI 14.9M
  • IPO Year
  • NEUP N/A
  • SISI 2016
  • Fundamental
  • Price
  • NEUP $7.01
  • SISI $0.21
  • Analyst Decision
  • NEUP Strong Buy
  • SISI
  • Analyst Count
  • NEUP 1
  • SISI 0
  • Target Price
  • NEUP $21.00
  • SISI N/A
  • AVG Volume (30 Days)
  • NEUP 22.3K
  • SISI 5.5M
  • Earning Date
  • NEUP 08-15-2025
  • SISI 05-15-2025
  • Dividend Yield
  • NEUP N/A
  • SISI N/A
  • EPS Growth
  • NEUP N/A
  • SISI N/A
  • EPS
  • NEUP 0.00
  • SISI N/A
  • Revenue
  • NEUP $15,662,715.00
  • SISI $9,601,324.00
  • Revenue This Year
  • NEUP N/A
  • SISI N/A
  • Revenue Next Year
  • NEUP N/A
  • SISI N/A
  • P/E Ratio
  • NEUP $4,149.50
  • SISI N/A
  • Revenue Growth
  • NEUP N/A
  • SISI 1133.26
  • 52 Week Low
  • NEUP $2.90
  • SISI $0.18
  • 52 Week High
  • NEUP $126.00
  • SISI $117.65
  • Technical
  • Relative Strength Index (RSI)
  • NEUP N/A
  • SISI 29.00
  • Support Level
  • NEUP N/A
  • SISI $0.18
  • Resistance Level
  • NEUP N/A
  • SISI $0.34
  • Average True Range (ATR)
  • NEUP 0.00
  • SISI 0.05
  • MACD
  • NEUP 0.00
  • SISI -0.01
  • Stochastic Oscillator
  • NEUP 0.00
  • SISI 11.25

About NEUP Neuphoria Therapeutics Inc. Common Stock

Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.

About SISI Shineco Inc.

Shineco Inc aims to care for a healthy life and improve the quality of life by providing safe, efficient, and high-quality health products and services to society. The company has researched and developed various vitro diagnostic reagents and related medical devices to date, and it also produces and sells healthy and nutritious food.

Share on Social Networks: